- Home
- FBRX vs FAAS Comparison
FBRX vs FAAS Comparison
Compare FBRX & FAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- FAAS
- Stock Information
- Founded
- FBRX N/A
- FAAS 2021
- Country
- FBRX United States
- FAAS Indonesia
- Employees
- FBRX N/A
- FAAS N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- FAAS
- Sector
- FBRX Health Care
- FAAS
- Exchange
- FBRX Nasdaq
- FAAS NYSE
- Market Cap
- FBRX 35.3M
- FAAS 34.6M
- IPO Year
- FBRX N/A
- FAAS N/A
- Fundamental
- Price
- FBRX $7.35
- FAAS $0.27
- Analyst Decision
- FBRX Strong Buy
- FAAS
- Analyst Count
- FBRX 4
- FAAS 0
- Target Price
- FBRX $76.58
- FAAS N/A
- AVG Volume (30 Days)
- FBRX 54.6K
- FAAS 249.6K
- Earning Date
- FBRX 05-12-2025
- FAAS 01-01-0001
- Dividend Yield
- FBRX N/A
- FAAS N/A
- EPS Growth
- FBRX N/A
- FAAS N/A
- EPS
- FBRX N/A
- FAAS N/A
- Revenue
- FBRX N/A
- FAAS $57,730,593.00
- Revenue This Year
- FBRX N/A
- FAAS N/A
- Revenue Next Year
- FBRX N/A
- FAAS N/A
- P/E Ratio
- FBRX N/A
- FAAS N/A
- Revenue Growth
- FBRX N/A
- FAAS 38.16
- 52 Week Low
- FBRX $4.11
- FAAS $0.23
- 52 Week High
- FBRX $28.68
- FAAS $10.68
- Technical
- Relative Strength Index (RSI)
- FBRX 44.84
- FAAS 32.91
- Support Level
- FBRX $7.10
- FAAS $0.27
- Resistance Level
- FBRX $9.04
- FAAS $0.31
- Average True Range (ATR)
- FBRX 1.32
- FAAS 0.07
- MACD
- FBRX 0.34
- FAAS -0.01
- Stochastic Oscillator
- FBRX 50.62
- FAAS 10.37
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About FAAS DIGIASIA CORP
DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.